Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID05790603

Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemostasis After CAG/PCI: a Randomized Controlled Trial

Led by Peking University First Hospital · Updated on 2024-07-11

200

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

P

Peking University First Hospital

Lead Sponsor

X

Xuanwu Hospital, Beijing

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the hemostatic effect of two different devices on radial arteries after coronary angiography (CAG) or percutaneous coronary intervention (PCI). This clinical trial aims to compare a patent hemostatic device with quantitative pressure to a conventional hemostatic device without pressure monitoring. The study focuses on understanding the hemostatic effect, precise pressure, and time needed to stop bleeding after these procedures. Participants will be randomly assigned to one of two groups. The intervention group will use the PHD-Band device that applies pressure based on the patient's systolic blood pressure plus 10 mmHg, with pressure gradually released over three hours, adjusting automatically if bleeding occurs. The control group will use the TR-Band device inflated with air and gradually deflated over three hours, with adjustments if bleeding happens. Both devices are applied at the radial artery entry site after removing the sheath used in the procedure. During the study, researchers will monitor participants for complications such as bleeding, hematoma, pain, hand swelling, numbness, pseudoaneurysm, and artery narrowing. Ultrasound scans will be used within 24 hours and again at 30 days to check for artery occlusion and other issues. The main outcome measured is the rate of radial artery occlusion 24 hours after the procedure, with additional outcomes including bleeding, time to hemostasis, and other complications. Participants will be followed for at least 30 days after treatment.

CONDITIONS

Brief Title

Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemostasis After CAG/PCI

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing coronary angiography or percutaneous coronary intervention via the radial artery
  • Positive Allen's test result
  • Willing to sign informed consent
Not Eligible

You will not qualify if you...

  • Radial artery malformation
  • Chronic kidney disease with eGFR less than 30 ml/min/1.73m2
  • Cirrhosis of the liver
  • Coagulation dysfunction
  • Patients treated with IIb / IIIa receptor antagonist

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Approximately 3 to 6 hours

Participants undergo percutaneous coronary intervention via the radial artery and receive either the PHD-Band with quantitative pressure or the TR-Band device for hemostasis at the puncture site. The compression devices are applied and adjusted over approximately 3 to 6 hours to stop bleeding.

1 procedure visit and monitoring during compression

Follow-up

Duration - 30 days

Participants are monitored for complications such as bleeding, hematoma, pain, swelling, numbness, pseudoaneurysm, and radial artery occlusion. Radial artery status is assessed by arterial ultrasound within 24 hours and again at 30 days after the procedure.

2 visits (within 24 hours and at 30 days post-procedure)

Trial Site Locations

Total: 2 locations

1

Xuanwu Hospital

Beijing, Beijing Municipality, China, 100053

Not Yet Recruiting

2

Peking University First Hospital

Beijing, China

Actively Recruiting

Loading map...

Research Team

Z

Zhenhui Tao

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

A Longitudinal Cohort of Patients With Acute Coronary Syndro...

Acute Coronary Syndrome

Actively Recruiting

1 location

A Randomized, Open Label, Parallel-group Study to Evaluate t...

No-Reflow Phenomenon

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Manual Versus Mechanical Compression of the Radial Artery After Transradial Coronary Angiography: The MEMORY Multicenter Randomized Trial.

Dimitrios Petroglou, Matthaios Didagelos, Georgios Chalikias...

https://pubmed.ncbi.nlm.nih.gov/29880098

The Design and Feasibility of the: Radial Artery Puncture Hemostasis Evaluation - RAPHE Study, a Prospective, Randomized, Multicenter Clinical Trial.

Péter Kulyassa, Balázs T Németh, Réka Ehrenberger...

https://pubmed.ncbi.nlm.nih.gov/35694680

Prevention of Radial Artery Occlusion of 3 Hemostatic Methods in Transradial Intervention for Coronary Angiography.

Guering Eid-Lidt, Jesús Reyes-Carrera, Julio I Farjat-Pasos...

https://pubmed.ncbi.nlm.nih.gov/35589232